DOE Embraces Synchrotron Radiation

Synchrotron radiation, once best known to high-energy physicists an an energy-sapping nuisance, is now emerging as an important new research area in its own right. First discovered in the early days of atom smashers, the radiation occurs when charged particles, such as electrons and protons; are rapidly accelerated. The more the particles are forced to speed up or change direction, the more energy they re-release as spontaneous radiation. That energy is, in effect, wasted in high-energy phy

Written byG. Christopher Anderson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Synchrotron radiation, once best known to high-energy physicists an an energy-sapping nuisance, is now emerging as an important new research area in its own right. First discovered in the early days of atom smashers, the radiation occurs when charged particles, such as electrons and protons; are rapidly accelerated. The more the particles are forced to speed up or change direction, the more energy they re-release as spontaneous radiation.

That energy is, in effect, wasted in high-energy physics, in which synchrotron radiation remains the principal limiting -factor in the design of new-machines. But for materials scientists, biologists, chemists, and microelectronics researchers, the phenomenon is proving to be more useful than previously thought possible. Because accelerated particles emit an unusually broad spectrum of radiation, scientists can isolate beams of nearly any wavelength from the “white light” of - radiation generated by modem, ring-shaped accelerators known as synchrotrons. Researchers have found they can ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies